The
global enteric disease testing market was valued at USD 3.1 billion
in 2012 and is expected to grow at a CAGR of 2.4% from 2013 to 2019,
to reach an estimated value of USD 3.6 billion in 2019.
Browse
the full report with complete TOC at Enteric Disease Testing Market
http://www.transparencymarketresearch.com/enteric-disease-testing-market.html
Enteric
diseases are major causes of morbidity and mortality worldwide.
Developing socio-economic countries with poor drainage, sanitation
along with overcrowding and low hygiene awareness account for
majority of enteric infection incidences prevailing worldwide. These
diseases usually exhibit mild symptoms but if not treated on time can
lead to severe complications, resulting in death. In order to manage
these diseases effectively, their early detection is essential.
Various enteric diseases responsible for diarrhea, stomach pain,
nausea, vomiting, anorexia, weight loss and fever are amebiasis,
giardiasis, rotavirus infection, salmonellosis and shigellosis.
Traditionally,
diagnosis of enteric infections relied on culture results of fecal
specimen. Today, the world is witnessing a paradigm shift from
culture to EIA (enzyme immunoassaya) and PCR (polymerase chain
reaction) based tests owing to advantages associated with these newer
testing methods.
Browse
Article of Enteric Disease Testing Market
http://www.transparencymarketresearch.com/article/enteric-disease-testing-market.htm
EIA
and PCR tests offer enhanced sensitivity and specificity compared to
culture tests and also give quick results. Globally the market for
enteric disease testing is growing at a CAGR of 2.4% under the
influence of rising awareness, demand for point of care testing and
increasing application of molecular diagnostics. Use of molecular
diagnostic products has made diagnosis easy and possible, even those
strains which once seemed to be difficult and impossible. North
America and Europe represent the largest regional markets because of
rapid demand for molecular based diagnostics and due to high level of
awareness among people about the diseases. C.difficile infection is
one of the major causes of antibiotic related diarrhea in developed
regions.
Request
for customization of this report
http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1258
Various
epidemiological sources including CDC and American Association for
Clinical Chemistry suggest that C.difficile infection incidence per
100,000 people has increased over the past few decades in United
States. In developing nations, frequent travelling to regions where
enteric diseases are epidemic is also one of the reasons driving the
market growth. Asia-Pacific and Africa have been predicted to grow
rapidly during the forecast period. In developing nations of
Asia-pacific, Africa and Latin America, the market is also growing
due to advent of rapid dipstick tests which can be applied by the
patient themself. These regions associated with inadequate healthcare
infrastructure do not possess substantial number of laboratories to
perform laboratory based tests. Thus, rapid dipstick test kits being
inexpensive and easy to use are widely accepted in these regions for
managing enteric illness. Continuously improving economy and rising
healthcare expenditure in these regions are also anticipated to drive
the market. The market is also growing due to emergence of new
strains; sources from Eurosurveillance suggest that the norovirus
infection is increasing worldwide, including United Kingdom, the
Netherlands, France, Japan and Australia due to emergence of new
strain of genotype II.4 (GII.4) that is also known as Sydney strain.
Browse
all Press Releases:
http://www.transparencymarketresearch.com/press-releases.htm
Some
of the major companies leading the market for enteric disease testing
are DiaSorin, Cepheid, Bio-Rad, Trinity Biotech, Biomerica, Becton
Dickinson, Meridian Bioscience, Alere and bioMerieux.
The
global enteric disease testing market is segmented into the following
categories:
Browse
all Article :
http://www.transparencymarketresearch.com/articles.htm
Enteric
Disease Testing Market, by types of diseases
Bacterial
Enteric Disease Testing
C.difficile
Infection
Campylobacteriosis
Cholera
E.coli
Infection
H.pylori
Infection
Salmonellosis
Shigellosis
Viral
Enteric Disease Testing
Rotavirus
Infection
Norovirus
Infection
Parasitic
Enteric Disease Testing
Amebiasis
Cryptosporidiosis
Giardiasis
Enteric
Disease Testing Market, by Geography
North
America
Europe
Asia-Pacific
Africa
Latin
America
Rest
of the World (RoW)
Browse
all Pharmaceutical Market Research Reports @
http://www.transparencymarketresearch.com/pharmaceutical-market-reports-1.html
About
Us
Transparency
Market Research is a global market intelligence company, providing
global business information reports and services. Our exclusive blend
of quantitative forecasting and trends analysis provides
forward-looking insight for thousands of decision makers. We are
privileged with highly experienced team of Analysts, Researchers, and
Consultants, who use proprietary data sources and various tools and
techniques to gather, and analyze information.
Our
data repository is continuously updated and revised by a team of
research experts, so that it always reflects the latest trends and
information. With a broad research and analysis capability,
Transparency Market Research employs rigorous primary and secondary
research techniques in developing distinctive data sets and research
material for business reports.
Contact
Sheela
AK
90
Sate Street, Suite 700
Albany,
NY 12207
Tel:
+1-518-618-1030
USA
- Canada Toll Free: 866-552-3453
Email:
sales@transparencymarketresearch.com
Blog:
http://www.tmrblog.com/
No comments:
Post a Comment